Investing.com - Taiwan Liposome ADR reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Taiwan Liposome ADR announced earnings per share of $-0.22 on revenue of $400.44K. Analysts polled by Investing.com anticipated EPS of $-0.09 on revenue of $586K.
Taiwan Liposome ADR shares are down 1.12% from the beginning of the year and are trading at $5.32 , down-from-52-week-high.They are under-performing the Nasdaq which is up 22.28% from the start of the year.
Taiwan Liposome ADR follows other major sector earnings this month
Taiwan Liposome ADR's report follows an earnings beat by L’Oreal ADR on July 30, who reported EPS of $3.82 on revenue of $6.92B, compared to forecasts EPS of $0.85 on revenue of $6.98B.
HSBC Holdings PLC ADR had missed expectations on Monday with second quarter EPS of $0.03 on revenue of $13.15B, compared to forecast for EPS of $0.27 on revenue of $13.29B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar